Pathfinder Cell Therapy Inc
PFND
Get informed when a big investor buys or sells
+ FollowMarket Cap$66.72K
Close$
Share Statistics
| Market cap | $66,716.00 |
|---|---|
| Enterprise Value | $5.48 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | -24.33 |
| Outstanding Shares | 667,161,000 |
Return
| Return on Equity | 20.58% |
|---|---|
| Return on Assets | -3551.28% |
| Return on Invested Capital | 11.52% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | -1.01 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.07 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | -0.8 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Pathfinder Cell Therapy Inc
1 employees